[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].

Abstract:

:This study is concerning 70 patients (57 female, 13 male) with an epidermoid carcinoma of the anal canal which were treated homogeneously with a combination of an external beam radiation therapy ((45 Gy in 25 fractions of 1.8 Gy for 5 weeks) and a brachytherapy with Iridium wires (15 to 20 Gy delivered to the gross residual disease). The N1 patients and the patients with tumors more than 4 cm in diameter received a chemotherapy also (5 FU and cisplatinum). The overall local control was obtained in 68 cases out of 70 (97.1%). 63 out of 70 patients (90%) are alive and locally controlled. 56 pts out of 70 (80%) did have a preserved anus, and a normal sphincterian function was preserved in 53 pts out of 70 (75.7%). 17 pts had a colostomy (3 without and 14 with an abdominoperineal resection). With the salvage perineal resection, 11 patients out of 12 local recurrences were definitely locally cured (91.7%). The 5-year overall survival is 91.4%. The 5-year disease-free survival is 90%. The 5-year survival with preserved anal sphincter is 80% and with preserved sphincterian function is 75.7%. Five patients died from cancer (3 deaths due to metastases, and only 2 due to a locoregional evolution). These results have been analysed regarding the literature data and demonstrated the curative role of external beam and brachytherapy, in localized tumors, the contribution of chemotherapy in advanced stages and the efficiency of secondary salvage surgery in local recurrences.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Dubois JB,Azria D,Ychou M

subject

Has Abstract

pub_date

2003-12-01 00:00:00

pages

1107-10

issue

12

eissn

0007-4551

issn

1769-6917

journal_volume

90

pub_type

杂志文章
  • [Nasopharyngeal epitheliomas: experience of the Regional Cancer Control Center in Lille (79 cases 1970-1982)].

    abstract::From 1970 to 1982, 79 cases of nasopharyngeal carcinomas were treated at the Regional Cancer Center of Lille (France). At the term of the study, it appears that patients of Central Europe origin have a rather high risk of NPC (17% of cases, that ethnic population representing about 8% of all superior aerodigestive tra...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lefebvre JL,Madelain M,Adenis L,Demaille MC,Delobelle A,Demaille A

    更新日期:1983-01-01 00:00:00

  • [Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

    abstract::Triple-negative breast cancer (TNBC), as defined by the absence of estrogen and progesterone receptor expression, as well as the lack of HER2 overexpression/amplification, corresponds to 15% of breast cancer and represents an aggressive form of the disease. TNBC are frequently confounded with basal subtype in the mole...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1740

    authors: Gonçalves A,Sabatier R,Charafe-Jauffret E,Gilabert M,Provansal M,Tarpin C,Extra JM,Viens P,Bertucci F

    更新日期:2013-05-01 00:00:00

  • [Towards an inventory of oncogenic mutations in cancer].

    abstract::The discovery of oncogenes and tumor suppressors has established the original concept of cancer development based on a cascade of spontaneously occurring somatic mutations. It is now well known that genomes of cancer cells are deeply rearranged and that these rearrangements have devastating consequences on their organ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1200

    authors: Theillet C

    更新日期:2010-11-01 00:00:00

  • [Radioimmunotargeting: diagnosis and therapeutic use].

    abstract::Monoclonal antibodies labeled with a radionuclide make feasible the in vivo radioimmunotargeting of tumor cells. This targeting could be performed for diagnosis, using gamma emitters, or for therapeutic purpose when antibodies are labeled with beta- and in the future alpha-emitters. Diagnosis applications (tumor detec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vuillez JP

    更新日期:2000-11-01 00:00:00

  • [Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial].

    abstract::Twenty-six patients with metastatic breast cancer where treated, after failure of a first line chemotherapy including an anthracycline, with a second line combination of vindesine, methotrexate and thiotepa. Overall tolerance of this treatment was good. There were one complete response and two partial responses. The a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Comoz M,Chevallier B,Bastit P

    更新日期:1988-01-01 00:00:00

  • [P53 genes and solid tumors].

    abstract::The p53 gene is known to play a central role in cancer. In fact, no human tumor type is devoid of p53 mutations, although differences can be seen in the relative frequencies and patterns of nucleotide substitutions. Our work illustrates these differences, since frequencies of mutations ranged from 15 to 80% and the pa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Theillet C

    更新日期:1993-08-01 00:00:00

  • [Radioimmunotherapy of follicular lymphoma: a step towards cure?].

    abstract::Advanced stage follicular lymphoma is incurable by conventional treatment. Important progress has been observed with the development of new therapies based on monoclonal antibodies and on the use of radioimmunotherapy (RIT) in the treatment of non-Hodgkin lymphomas (NHL). Rituximab in combination with chemotherapy in ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ketterer N,Bischof Delaloye A,Helg C,Luthi F,Buchegger F

    更新日期:2007-09-01 00:00:00

  • [Treatment of rhabdomyosarcoma in mice C3H/He by Co 60 and hyperbaric oxygen (author's transl)].

    abstract:UNLABELLED:Experimental study of rhabdomyosarcoma with successive transplantation upon C3H/He mice, treated by irradiation (Co 60) and combined irradiation-hyperbaric oxygen (HBO), dating from 3, 14 and 15 days after transplantation. The data (tumor volume evolution, histological modifications, pulmonary metastases) ar...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Agnius-Delord C,Couderc P,Laval P,Mourret A,Rinaldi R,Rinaldi C

    更新日期:1979-01-01 00:00:00

  • [ALL in adult patients: Contribution and limits of pediatric management].

    abstract::For two decades, the prognostic of adult patients with ALL was improved based on pediatric-inspired protocols. These approaches based on less myelosuppressive drugs have led to improved response rates, decreased relapse rates, with a benefit in survival observed in patients aged up to 50-60-years-old. Therapeutic inte...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.07.008

    authors: Rabian F,Boissel N

    更新日期:2020-09-24 00:00:00

  • [Gastrointestinal stromal tumours in pediatrics: a summary of the literature on this orphan disease].

    abstract::Recommendations for the management of gastrointestinal stromal tumours (GIST) in children and adolescents do presently not exist. Thus, a summary of the current literature was conducted serving as a basis for the development of optimal management strategies for childhood GIST. Pediatric cases of GIST may occur sporadi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1296

    authors: Verschuur A,André N,Blay JY

    更新日期:2011-01-01 00:00:00

  • [Melanomas of the female genital tract: state of the art].

    abstract::Melanoma of the female genital tract is a rare location (less than 2% of melanomas all sites combined). These cancers have a very poor prognosis, due to the delay in diagnosis. Vulvar location is about 1% of melanomas then the vaginal location, uterine and ovarian. There is no consensus to date regarding their care, d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1881

    authors: Trone JC,Guy JB,Mery B,Langrand Escure J,Lahmar R,Moncharmont C,Rivoirard R,Semay T,Chauleur C,Collard O,Vignot S,Magné N

    更新日期:2014-01-01 00:00:00

  • Remaining indications for total mastectomy in breast carcinoma

    abstract::Does radical mastectomy for cancer remain needed? Breast conserving treatment may be achieved by surgery, primary chemotherapy followed by radiotherapy and surgery. This article attempts at defining (according to clinical and pathological parameters of the tumor and patient's characteristics), when conservative treatm...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weber B,Demange L,Rigaud C,Fernandes-Valoni A

    更新日期:1998-09-01 00:00:00

  • [Endothelin receptors in benign human tumours of uterine muscle].

    abstract::The endothelins (ET1, ET2, ET3) are a family of peptides that exert vasoactive and mitogenic effects. ETs bind to at least two subtypes of receptors: the ETA subtype is ET1 selective whereas the ETB subtype binds ET1, ET2 and ET3. By RT-PCR, we detected ETA receptor mRNA and ETB receptor mRNA in leiomyoma and in homol...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breuiller-Fouché M,Honoré JC,Robert B,Fournier T,Vacher-Lavenu MC,Chapron C,Dubuisson JB,Ferré F

    更新日期:1999-09-01 00:00:00

  • [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

    abstract:CONTEXT:The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals, as well as private clinics and medical specialty societies. ...

    journal_title:Bulletin du cancer

    pub_type: 指南,杂志文章,实务指引

    doi:

    authors: Denoux Y,Blanc-Vincent MP,Simony-Lafontaine Jl,Verriele-Beurrier V,Briffod M,Voigt JJ

    更新日期:2002-04-01 00:00:00

  • [Supportive care for survivors].

    abstract::Advances in early detection and treatment have pushed in a few decades the management of cancers from a management model of the end of life to the management of a chronic disease. This evolution has accelerated the development of supportive care in two directions, firstly towards the best possible support to the end o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.007

    authors: Ninot G,Debourdeau P,Blanc-Legier F,De Crozals F,De Rauglaudre G,Khouri S,Kirscher S,Mineur L,Piollet I,Sant I,Schillinger P,Serin D

    更新日期:2018-09-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [Pharmacology of platinum analogs-taxanes interactions].

    abstract::Taxoids and platinum derivatives display a true activity against many types of solid tumors. Their relatively non overlapping toxicity profiles and their different mechanisms of action made their combination attractive. Actually, the frequency and the severity of the toxicity appeared schedule-dependent. Thus, cisplat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Boisdron-Celle M,Gamelin E

    更新日期:2000-08-01 00:00:00

  • On the value of response criteria in therapeutic research.

    abstract::Primary chemotherapy is the use of anticancer drugs as the first treatment in patients with localized tumor presentations for which there is an alternative but less than satisfactory treatment. Its most important feature is the preservation of the primary tumor mass as a biologic marker of response, and in this sense ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Devita VT Jr

    更新日期:1988-01-01 00:00:00

  • [Integrins, cell response to anti-tumor agents and chemoresistance].

    abstract::Integrins are a family of heterodimeric transmembrane receptors that mediate cell-cell and cell-extracellular matrix adhesion. Integrin-mediated signaling is essential for the regulation of fundamental cellular functions, including proliferation and survival, and for tumor development. According to in vitro studies, i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Maubant S,Staedel C,Gauduchon P

    更新日期:2002-11-01 00:00:00

  • [Spontaneous transformation and long term culture of foetal mouse glial cells (author's transl)].

    abstract::Six cell lines originated from foetal mouse brain were maintained in vitro for more than two years. The morphology of most of these cultures suggests their glial character. This is corroborated, for some lines, by the presence of specific glial protein (Glial fibrillary acidic protein, or GFAP). Five out of these line...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coulomb B,Levy S,Maunoury R,Markovits P

    更新日期:1979-01-01 00:00:00

  • [Rare cancers and new radiotherapy techniques].

    abstract::Rare cancers represent about a quarter of all cancers diagnosed in Europe, and their incidence is increasing. Meanwhile, scientific advances provide techniques, which become more and more sophisticated in the domain of radiotherapy. Treatment options for radiotherapy rare cancers are increasing, but are not yet evalua...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.12.001

    authors: Espenel S,Trone JC,Vallard A,Guy JB,Moriceau G,Méry B,Langrand-Escure J,Rivoirard R,de Laroche G,Chargari C,Magné N

    更新日期:2015-01-01 00:00:00

  • [New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?].

    abstract::The transcription factor MyoD, member of the myogenic regulators family, induces differentiation in precursor cells by its ability to arrest cell proliferation and to activate muscle specific genes. MyoD plays a key role in the antagonism between proliferation and differentiation. The withdrawal from the cell cycle an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Tintignac LA,Leibovitch MP,Leibovitch SA

    更新日期:2001-06-01 00:00:00

  • [Axillary lymphadenectomy prepared by fat aspiration versus functional axillary lymphadenectomy: preliminary results of a randomized prospective study].

    abstract::The objective of this study is to compare morbidity between 2 surgical procedures of axillary clearance: functional lymphadenectomy by classical dissection versus axillary dissection prepared by liposuction (Suzanne's procedure). Two hundred consecutive patients treated for breast cancer were included in a prospective...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Giard S,Laurent JC,Dron AM,Lefebvre D

    更新日期:1997-03-01 00:00:00

  • [Neoadjuvant treatment for unresectable pancreatic tumors: Against!].

    abstract::Should we consider surgery for pancreatic cancer when resectability seems initially uncertain? The answer is no consensual as illustrated by the controversy presented here. This article presents the key arguments against surgery. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(15)31231-5

    authors: Évrard S

    更新日期:2015-06-01 00:00:00

  • [Recent data on the immunology of tumors. Mechanisms of escape of immunological control. Role of suppressor cells].

    abstract::Cells in spleens from tumor bearing animals were found to inhibit in vitro reactivity of lymphocytes to a variety of stimulants. These suppressor cells inhibited the stimulation of normal lymphocytes by mitogens : P.H.A.-Con A-L.P.S. They were adherent cells, bore immunoglobulins at their surface and did not bear the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lespinats G,Poupon MF

    更新日期:1976-04-01 00:00:00

  • [Life style and occupational factors and prevention of second primary cancers after childhood and adolescent cancer: Current state of knowledge].

    abstract:CONTEXT:Survival of children, adolescents and young adults treated for cancer increased with improved treatments. But there is still an increased risk of second primary cancer (SPC) in the long term compared to the population of the same age, especially related to treatments. A reflection on the follow-up of this popul...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.017

    authors: Duval S,Carretier J,Boyle H,Philip T,Berger C,Marec-Bérard P,Fervers B

    更新日期:2015-07-01 00:00:00

  • [Urothelial tumors in children].

    abstract::Urothelial tumors are very rare in children (to date, only about 150 cases have been reported worlwide). Only 20% occur before the age of ten. The aim of this study is to specify the clinicopathologic features of urothelial tumor in young patients, which require a slightly different approach to treatment. On the basis...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.018

    authors: Grapin-Dagorno C,Peycelon M,Philippe-Chomette P,Berrebi D,El Ghoneimi A,Orbach D

    更新日期:2017-02-01 00:00:00

  • [Percutaneous ablation of metastases: where are we and new techniques].

    abstract::When a metastatic disease is localized and slowly evolving either spontaneously or after a general treatment, a local treatment may be proposed. For about 15 years, image-guided percutaneous ablation has been developed which allows to treat tumors with temperature modifications. These mini-invasive techniques may be r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1728

    authors: Palussière J,Buy X,Fonck M

    更新日期:2013-04-01 00:00:00

  • [Long-term occupational situation after cancer: A French registry-based study].

    abstract:INTRODUCTION:Few studies have explored the long-term occupational situation after cancer. The aim of our study were to study the employment status among long-term cancer survivors and to compare it to cancer-free controls from the general population at 5, 10 or 15 years after cancer diagnosis. METHODS:From data of a r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.06.004

    authors: Saim A,Gernier F,Licaj I,Rod J,Velten M,Klein D,Mercier M,Joly F

    更新日期:2020-09-01 00:00:00

  • Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?

    abstract:BACKGROUND:We analyzed renal cell carcinoma (RCC) brain metastasis (BM) risk factors and compared BM occurrence in metastatic RCC (mRCC) treated with or without anti-angiogenic agents (AA). METHODS:Data from all consecutive metastatic RCC patients (patients) treated in a french cancer center between 1995 and 2008 were...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1672

    authors: Vanhuyse M,Penel N,Caty A,Fumagalli I,Alt M,Zini L,Adenis A

    更新日期:2012-12-01 00:00:00